UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 22.

Trinh, H V; Lesage, G; Chennamparampil, V; Vollenweider, B; Burckhardt, C J; Schauer, S; Havenga, M; Greber, U F; Hemmi, S (2012). Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection. Journal of Virology, 86(3):1623-1637.

Buschmann, J; Welti, M; Hemmi, S; Neuenschwander, P; Baltes, C; Giovanoli, P; Rudin, M; Calcagni, M (2011). 3D co-cultures of osteoblasts and endothelial cells in DegraPol foam: Histological and high field MRI analyses of pre-engineered capillary networks in bone grafts. Tissue engineering. Part C, 17(3-4):291-299.

Lütschg, V; Boucke, K; Hemmi, S; Greber, U F (2011). Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells. Nature Communications, 2:391.

Burckhardt, C J; Suomalainen, M; Schoenenberger, P; Boucke, K; Hemmi, S; Greber, U F (2011). Drifting Motions of the Adenovirus Receptor CAR and Immobile Integrins Initiate Virus Uncoating and Membrane Lytic Protein Exposure. Cell Host & Microbe, 10(2):105-117.

Hemmi, S; Vidovszky, M Z; Ruminska, J; Ramelli, S; Decurtins, W; Greber, U F; Harrach, B (2011). Genomic and phylogenetic analyses of murine adenovirus 2. Virus Research, 160(1-2):128-135.

Hemminki, O; Bauerschmitz, G; Hemmi, S; Lavilla-Alonso, S; Diaconu, I; Guse, K; Koski, A; Desmond, R A; Lappalainen, M; Kanerva, A; Cerullo, V; Pesonen, S; Hemminki, A (2010). Oncolytic adenovirus based on serotype 3. Cancer Gene Therapy, 18:288-296.

Kälin, S; Amstutz, B; Gastaldelli, M; Wolfrum, N; Boucke, K; Havenga, M; Digennaro, F; Liska, N; Hemmi, S; Greber, U F (2010). Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. Journal of Virology, 84(10):5336-5350.

Fontecedro, A C; Lutschg, V; Eichhoff, O; Dummer, R; Greber, U F; Hemmi, S (2010). Analysis of adenovirus trans-complementation-mediated gene expression controlled by melanoma-specific TETP promoter in vitro. Virology Journal, 7(1):175.

Schlegel, N C; Eichhoff, O M; Hemmi, S; Werner, S; Dummer, R; Hoek, K S (2009). Id2 suppression of p15 counters TGF-beta-mediated growth inhibition of melanoma cells.counters TGF-beta-mediated growth inhibition of melanoma cells. Pigment Cell & Melanoma Research, 22(4):445-453.

Amstutz, B; Gastaldelli, M; Kälin, S; Imelli, N; Boucke, K; Wandeler, E; Mercer, J; Hemmi, S; Greber, U F (2008). Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3. EMBO Journal, 27(7):956-969.

Hoek, K S; Eichhoff, O M; Schlegel, N C; Döbbeling, U; Kobert, N; Schaerer, L; Hemmi, S; Dummer, R (2008). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Research, 68(3):650-656.

Fleischli, C; Sirena, D; Lesage, G; Havenga, M J E; Cattaneo, R; Greber, U F; Hemmi, S (2007). Species B adenovirus serotypes 3, 7, 11 and 35 share similar binding sites on the membrane cofactor protein CD46 receptor. Journal of General Virology, 88(11):2925-2934.

Schmitz, M; Graf, C; Gut, T; Sirena, D; Peter, I; Dummer, R; Greber, U F; Hemmi, S (2006). Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses. Gene Therapy, 13(11):893-905.

Sirena, D; Ruzsics, Z; Schaffner, Walter; Greber, U F; Hemmi, S (2005). The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3. Virology, 343(2):283-298.

Fleischli, C; Verhaagh, S; Havenga, M; Sirena, D; Schaffner, Walter; Cattaneo, R; Greber, U F; Hemmi, S (2005). The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35. Journal of Virology, 79(15):10013-10022.

Meier, O; Gastaldelli, M; Boucke, K; Hemmi, S; Greber, U F (2005). Early steps of clathrin-mediated endocytosis involved in phagosomal escape of Fcgamma receptor-targeted adenovirus. Journal of Virology, 79(4):2604-2613.

Sirena, D; Lilienfeld, B; Eisenhut, M; Kälin, S; Boucke, K; Beerli, R R; Vogt, Lorenz; Ruedl, C; Bachmann, M F; Greber, U F; Hemmi, S (2004). The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. Journal of Virology, 78(9):4454-4462.

Imelli, N; Meier, O; Boucke, K; Hemmi, S; Greber, U F (2004). Cholesterol is required for endocytosis and endosomal escape of adenovirus type 2. Journal of Virology, 78(6):3089-3098.

Nagel, H; Maag, S; Tassis, A; Nestlé, F O; Greber, U F; Hemmi, S (2003). The alphavbeta5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses. Gene Therapy, 10(19):1643-1653.

Peter, I; Graf, C; Dummer, R; Schaffner, W; Greber, U F; Hemmi, S (2003). A novel attenuated replication-competent adenovirus for melanoma therapy. Gene Therapy, 10(7):530-9.

Meier, O; Boucke, K; Hammer, S V; Keller, S; Stidwill, R P; Hemmi, S; Greber, U F (2002). Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. Journal of Cell Biology, 158(6):1119-1131.

Ebbinghaus, C; Al-Jaibaji, A; Operschall, E; Schöffel, A; Peter, I; Greber, U F; Hemmi, S (2001). Functional and selective targeting of adenovirus to high-affinity Fcgamma receptor I-positive cells by using a bispecific hybrid adapter. Journal of Virology, 75(1):480-489.

This list was generated on Fri Jul 28 17:34:01 2017 CEST.